The Withdrawal Ease website says that Catlin started the company because of his personal experience with opiate prescription painkillers after he was diagnosed with severe cervical spinal stenosis.
It specifically takes issue these claims: that Withdrawal Ease can alleviate the symptoms of opiate withdrawal; that Withdrawal Ease increases the chances of a person overcoming opiate dependency; and that Recovery Ease significantly alleviates post acute withdrawal symptoms.
A court order has since been entered to settle the FTC’s charges against Catlin. It prohibits the company from making health-related claims, including claims that its products can alleviate withdrawal symptoms or help with drug dependency, unless the claims are not misleading and are supported by scientific evidence.
Another excerpt from Catlin’s website said: “The Withdrawal-Ease Opiate Withdrawal Natural Supplement System employs ingredients that have been proven efficacious under rigorous clinical trials. There is no other product like the Withdrawal-Ease System on the market today; it’s the most effective and advanced natural treatment for opiate withdrawal and detox that you can buy.”
The order also imposes a $6.6 million judgment against Catlin for consumer injury and disgorgement of ill-gotten gains, but the FTC says the judgment will be suspended based on his inability to pay.
AUSTIN, Texas (CN) – An Austin-based company selling home detox products agreed to settle claims by the Federal Trade Commission that its herbal products don’t actually alleviate symptoms of opiate dependency.
The company’s statements that clinical studies backed up its product claims are likewise dubious, the FTC alleges.
The FTC filed a lawsuit Wednesday in Austin federal court against Catlin Enterprises and its CEO George Catlin, alleging violations of the Federal Trade Commission Act and seeking an injunction to prevent further violations.